Back

Defibrillation threshold testing in hypertrophic cardiomyopathy: acute outcomes and long-term follow-up

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Arrhythmia management in patients with hypertrophic cardiomyopathy Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Yuri Bocchini

Heart and Diabetes Center NRW, Bad Oeynhausen (Germany)

5 More presentations in this session

Presentation thumbnail
Prognostic significance of artificial intelligence quantified late gadolinium enhancement in hypertrophic cardiomyopathy
Doctor Y. Jeong (Daegu, KR)
Abstract Slides Video
Presentation thumbnail
Electromechanical predictors of haemodynamic and clinical efficacy of electro-mechanically optimised RV pacing for obstructive hypertrophic cardiomyopathy: a stratified analysis of EMORI-HCM
Doctor J. Mohal (London, GB)
Abstract Slides Video
Presentation thumbnail
Long-term outcomes of catheter ablation for sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy
Doctor A. Keresteci (Ankara, TR)
Abstract Slides Video
Presentation thumbnail
Predictors of recurrent ventricular arrhythmias and the impact of genetic testing in a hypertrophic cardiomyopathy patient cohort at long term follow up
Doctor H. Moore (Somerset nhs Foundation, GB)
Abstract Slides Video
Presentation thumbnail
Impact of phenotypic profile and genotype on ventricular tachycardia ablation outcomes in hypertrophic cardiomyopathy
Doctor A. Meretta (Leiden, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Arrhythmia management in patients with hypertrophic cardiomyopathy

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Predictors of recurrent ventricular arrhythmias and the impact of genetic testing in a hypertrophic cardiomyopathy patient cohort at long term follow up
thumbnail
Congress Presentation
Can we predict if defibrillation testing of a subcutaneous implantable cardioverter defibrillator can be avoided safely at device replacement?
thumbnail
Congress Presentation
The predictive value of impedance for defibrillation success after subcutaneous implantable cardioverter-defibrillator implantation: a reliable indicator?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources